COMMUNIQUÉS West-GlobeNewswire

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/12/2024 - 22:05

BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on December 2, 2024, [...]

Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting

03/12/2024 - 22:05

ADELAIDE, Australia and CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric [...]

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

03/12/2024 - 22:05

The Phase 1b study will evaluate LV UNO in unresectable cutaneous or subcutaneous histologically confirmed primary or metastatic solid tumor cancer patients that have progressed or have prolonged stable disease on [...]

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update

03/12/2024 - 22:05

— Enhanced liquidity through issuance of Second Lien Notes — Obtained amendment to credit agreement and extended note payable — Fourth quarter fiscal 2024 revenue down 7.3% to $130.4 million — Full year fiscal 2024 [...]

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

03/12/2024 - 22:01

SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03/12/2024 - 22:01

CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

03/12/2024 - 22:01

WATERTOWN, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”) a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/12/2024 - 22:00

SOUTH SAN FRANCISCO, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 29, 2024 it granted stock options to purchase an aggregate of 34,515 shares of [...]

Inc. Names Precision Neuroscience to 2024 Best in Business List

03/12/2024 - 21:19

The annual list recognizes the brain–computer interface company as a leader in the field and for its positive impact on society NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision [...]

NFL Star DK Metcalf Selects SOUND Behavioral Health as Partner for “My Cause My Cleats” Awareness Campaign

03/12/2024 - 21:04

Seattle Seahawks wide receiver aims to raise awareness and support for Deaf community by showcasing SOUND Behavioral Health’s Deaf Services Program TUKWILA, Wash., Dec. 03, 2024 (GLOBE NEWSWIRE) -- SOUND Behavioral [...]

ACTG Announces Publication of BEe-HIVe Trial in JAMA

03/12/2024 - 19:04

Data demonstrate superiority of HepB-CpG vaccination over conventional hepatitis B vaccines among people living with HIV LOS ANGELES, Dec. 03, 2024 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on [...]

PhotoniCare Announces a First Close of $4.6 Million in Series B Financing, a Manufacturing Partnership with Gentex Corporation, and Relocation of its Headquarters to Grand Rapids, Michigan

03/12/2024 - 17:08

GRAND RAPIDS, Mich., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PhotoniCare Inc., a medical device company dedicated to delivering innovation to frontline care that demonstrably enhances patient outcomes, is pleased to announce [...]

Kno2 announces new PreCheck system to improve patient data security and accuracy

03/12/2024 - 17:05

New system reduces the need to store patient data and accelerates patient matching processes BOISE, Idaho, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Kno2®, the leader in healthcare communication, is proud to announce Kno2 [...]

Former Merck USA President Joins Klotho Neurosciences’ Board of Directors

03/12/2024 - 17:00

Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ), a U.S.-based biotechnology company [...]

Corza Medical named #14 on Top 100 Healthcare Technology Companies of 2024

03/12/2024 - 16:58

WESTWOOD, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”), a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, was [...]

H.H.C. Group Supports Self-Insured Stakeholders with Rapid Turnaround Cost-Containment Solutions to Address High Volume of Year-End Claims

03/12/2024 - 16:02

ROCKVILLE, Md., Dec. 03, 2024 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C), the leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]

Brain Cancer Canada, a leading advocate in the fight against brain cancer, is proud to award a $100,000 research grant to one of Canada’s top neuropathologists to support research on one of the deadliest pediatric brain cancers

03/12/2024 - 16:00

TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to announce a $100,000 pediatric research grant awarded to Dr. Cynthia Hawkins, neuropathologist-scientist, and her team at the Hospital for Sick [...]

Upgrade of revenue and operating profit guidance

03/12/2024 - 15:56

ANNOUNCEMENT NO. 285 3 December 2024 Upgrade of revenue and operating profit guidance ChemoMetec sustained its positive performance in the second quarter of 2024/25 with better-than-expected sales and order intake. [...]

HealthEquity 2025 Benefits Trends Unveiled: Cost Transparency and Containment Take Center Stage for Administrators

03/12/2024 - 15:20

SHRM-hosted event will focus on tactics and takeaways to help employers combat rising costs that affect employee satisfaction and benefits utilization DRAPER, Utah, Dec. 03, 2024 (GLOBE NEWSWIRE) -- HealthEquity has [...]